Search research articles
Contact Us
Filters
Showing results (131-140 of 166) with videos related to
Page
of 17
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
Hoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Science Immunology
|
May 19, 2021
Pharmacological activation of STING blocks SARS-CoV-2 infection
Minghua Li, Max Ferretti, Baoling Ying, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Immune history shapes human antibody responses to H5N1 influenza viruses
Tyler A Garretson, Jiaojiao Liu, Shuk Hang Li, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 2021
Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Xiaolei Liu, Anurag Verma, Gustavo Garcia, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2021
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition
Xiaolei Liu, Anurag Verma, Gustavo Garcia, et al.
Nature Medicine
|
March 14, 2025
Immune history shapes human antibody responses to H5N1 influenza viruses
Tyler A Garretson, Jiaojiao Liu, Shuk Hang Li, et al.
Cell Host & Microbe
|
February 21, 2020
An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis
Arthur S Kim, Ofer Zimmerman, Julie M Fox, et al.
Nature
|
February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 166) with videos related to
Sort By:
Page
of 17
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
Hoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Science Immunology
|
May 19, 2021
Pharmacological activation of STING blocks SARS-CoV-2 infection
Minghua Li, Max Ferretti, Baoling Ying, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Immune history shapes human antibody responses to H5N1 influenza viruses
Tyler A Garretson, Jiaojiao Liu, Shuk Hang Li, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 2021
Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Xiaolei Liu, Anurag Verma, Gustavo Garcia, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2021
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition
Xiaolei Liu, Anurag Verma, Gustavo Garcia, et al.
Nature Medicine
|
March 14, 2025
Immune history shapes human antibody responses to H5N1 influenza viruses
Tyler A Garretson, Jiaojiao Liu, Shuk Hang Li, et al.
Cell Host & Microbe
|
February 21, 2020
An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis
Arthur S Kim, Ofer Zimmerman, Julie M Fox, et al.
Nature
|
February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
Page
of 17